Norwegian biotechnology company NorDiag has chosen metro Atlanta for its North American headquarters.

The company will add biotech jobs over the next three years. NorDiag estimates that its Alpharetta facility will create 10-20 high-paying jobs. NorDiag was founded in 2003 and is headquartered in Oslo, Norway. The company develops, manufactures and markets instrumentation and reagents for the clinical and life sciences markets that automate the process of nucleic acid extraction and cell separation from specimens.

“This location is centrally located to our current and potential customers and provides a wealth of resources for us to draw from, including the university systems located in Atlanta and the Centers for Disease Control and Prevention.  We look forward to our continued growth here,” said Tim Murray, President & General Manager of NorDiag U.S.

NorDiag’s Alpharetta facility is located within the Innovation Crescent, the 13 county region spanning Atlanta to Athens, which is home to 95 percent of the region’s biotechnology resources.

Chris Cummiskey, commissioner of the Georgia Department of Economic Development, highlighted that Georgia’s growing presence in the biotechnology and life sciences arena gets a major boost when global companies like NorDiag choose to locate in the state.

1. Plans Shared For 25,000 New Biotech Jobs In Georgia
2. Hope For More Biotech Jobs In Georgia
3. New Biotech Jobs Emerge In North Carolina
4. Passage of America Invents Act To Result In Biotech Jobs
5. New Facility To Result In Biotech Jobs In Georgia